NumerixS Investment Technologies’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-800	Closed	-$64K	–	1032
2019 Q3	$64K	Buy	+800	New	+$63.3K	0.02%	668
2018 Q4	–	Sell	-13,791	Closed	-$1.24M	–	1060
2018 Q3	$1.24M	Buy	13,791 +9,691	+236%	+$975K	0.23%	111
2018 Q2	$398K	Buy	+4,100	New	+$407K	0.09%	313
2017 Q4	–	Sell	-2,400	Closed	-$282K	–	1112
2017 Q3	$282K	Buy	+2,400	New	+$205K	0.06%	399
2017 Q2	–	Sell	-1,000	Closed	-$51K	–	1106
2017 Q1	$51K	Sell	1,000 -200	-17%	-$9.24K	0.01%	1009
2016 Q4	$45K	Buy	+1,200	New	+$50.2K	0.01%	974
2016 Q2	–	Sell	-7,800	Closed	-$490K	–	1101
2016 Q1	$490K	Buy	+7,800	New	+$519K	0.06%	471
2015 Q4	–	Sell	-7,100	Closed	-$571K	–	758
2015 Q3	$571K	Sell	7,100 -3,300	-32%	-$367K	0.07%	346
2015 Q2	$1.25M	Buy	10,400 +3,500	+51%	+$418K	0.17%	160
2015 Q1	$720K	Buy	+6,900	New	+$699K	0.13%	208